Market Research Logo

Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review

Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lead product, Migalastat HCl, a small molecule is used for the treatment of Fabry disease. The other development products in the pipeline include ATB200 for the treatment of pompe disease; SD-101 for Epidermolysis Bullosa (EB), chronic, rare connective tissue disorder; and enzyme replacement therapies for other rare diseases. It has presence in the US, the UK, Ireland, France, the Netherlands, Germany, Spain, Italy and Japan. Amicus Therapeutics is headquartered in Cranbury, New Jersey, the US.

Amicus Therapeutics Inc Key Recent Developments

Jun 08,2018: Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors
May 08,2018: Amicus Therapeutics Announces First Quarter 2018 Financial Results and Corporate Updates
Feb 28,2018: Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates
Feb 27,2018: Amicus Therapeutics Launches Healing Beyond Disease Initiatives to Change People’s Lives Living with Rare Diseases
Jan 08,2018: Amicus Therapeutics Provides Full-Year 2018 Strategic Outlook and Financial Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Amicus Therapeutics Inc - Key Facts
Amicus Therapeutics Inc - Key Employees
Amicus Therapeutics Inc - Key Employee Biographies
Amicus Therapeutics Inc - Major Products and Services
Amicus Therapeutics Inc - History
Amicus Therapeutics Inc - Company Statement
Amicus Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amicus Therapeutics Inc - Business Description
Amicus Therapeutics Inc - Corporate Strategy
Amicus Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Amicus Therapeutics Inc - Strengths
Amicus Therapeutics Inc - Weaknesses
Amicus Therapeutics Inc - Opportunities
Amicus Therapeutics Inc - Threats
Amicus Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Amicus Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 08, 2018: Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors
May 08, 2018: Amicus Therapeutics Announces First Quarter 2018 Financial Results and Corporate Updates
Feb 28, 2018: Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates
Feb 27, 2018: Amicus Therapeutics Launches Healing Beyond Disease Initiatives to Change People’s Lives Living with Rare Diseases
Jan 08, 2018: Amicus Therapeutics Provides Full-Year 2018 Strategic Outlook and Financial Guidance
Nov 08, 2017: Amicus Therapeutics Announces Third Quarter 2017 Financial Results and Corporate Updates
Oct 06, 2017: Amicus Therapeutics Appoints Michael C. Diem, MD as Senior Vice President of Business and Corporate Development
Aug 07, 2017: Amicus Therapeutics Announces Second Quarter 2017 Financial Results and Corporate Updates
May 09, 2017: Amicus Therapeutics Announces First Quarter 2017 Financial Results and Corporate Updates
Mar 01, 2017: Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Amicus Therapeutics Inc, Key Facts
Amicus Therapeutics Inc, Key Employees
Amicus Therapeutics Inc, Key Employee Biographies
Amicus Therapeutics Inc, Major Products and Services
Amicus Therapeutics Inc, History
Amicus Therapeutics Inc, Other Locations
Amicus Therapeutics Inc, Subsidiaries
Amicus Therapeutics Inc, Key Competitors
Amicus Therapeutics Inc, Ratios based on current share price
Amicus Therapeutics Inc, Annual Ratios
Amicus Therapeutics Inc, Annual Ratios (Cont...1)
Amicus Therapeutics Inc, Interim Ratios
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Amicus Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Amicus Therapeutics Inc, Performance Chart (2013 - 2017)
Amicus Therapeutics Inc, Ratio Charts
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report